secwatch.observer — SEC 8-K summary
======================================

Issuer:     enVVeno Medical Corp (NVNO)
CIK:        0001661053
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001641172-25-011729
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enVVeno Medical appoints Jennifer Bright as CFO, replacing Craig Glynn
----------------------------------------------------------------------

- Craig Glynn resigned as CFO effective May 19, 2025; will serve as consultant for transition.
- Jennifer Bright appointed CFO; 25+ yr CPA, ex-CFO of BIOLASE, salary $300K, bonus up to 40%.
- Bright awarded 350,000 stock options at $3.62/share, vesting over 3 years with 1-year cliff.
- No disagreement with Glynn; standard employment and indemnification agreements signed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/0001641172-25-011729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer